FAP and fibrosarcoma: For instance, in a murine fibrosarcoma model (MCA205) stably expressing FAP, treatment with 60 MBq of the radiopharmaceutical 177Lu-FAP-2287 in combination with an anti-PD-1 immune checkpoint inhibitor resulted in a greater infiltration of CD45+ leukocytes compared to monotherapy.